Editorial

World Journal of Biological Psychiatry

Volumn 9, Issue 1, 2008, Pages 2-5

  Wolkowitz, Owen M ^a   Epel, Elissa S ^a   Mellon, Synthia ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GLUCOCORTICOID; TELOMERASE; BIOLOGICAL MARKER; HYDROCORTISONE;

APOPTOSIS; BIPOLAR DISORDER; BRAIN; CARDIOVASCULAR DISEASE; CELL AGING; CELL DAMAGE; CENTRAL NERVOUS SYSTEM; COMORBIDITY; DEMENTIA; DEPRESSION; EDITORIAL; ENZYME ACTIVITY; HIPPOCAMPUS; HUMAN; MENTAL STRESS; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; OSTEOPOROSIS; OXIDATIVE STRESS; PATHOPHYSIOLOGY; RISK FACTOR; STEM CELL; SYMPTOM; TELOMERE; DOWN REGULATION; METABOLISM; PHYSIOLOGY;

BIOLOGICAL MARKERS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL AGING; DEPRESSION; DOWN-REGULATION; HIPPOCAMPUS; HUMANS; HYDROCORTISONE; OXIDATIVE STRESS; STRESS, PSYCHOLOGICAL; TELOMERASE; TELOMERE;

EID: 39149126339     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.1080/15622970701875601     Document Type: Editorial

References (40)

1. Akiyama, M., Hideshima, T. and Hayashi, T. (2002) Cytokines modulate telomerase activity in a human multiple myeloma cell line. Cancer Res, 62, pp. 3876-3882.
2. Akiyama, M., Yamada, O. and Hideshima, T. (2004) TNFalpha induces rapid activation and nuclear translocation of telomerase in human lymphocytes. Biochem Biophys Res Commun, 316, pp. 528-532.
3. Aviv, A. (2006) Telomeres and human somatic fitness. J Gerontol A Biol Sci Med Sci, 61, pp. 871-873.
4. Brouilette, S., Singh, RK, Thompson, JR, Goodall, AH and Samani, NJ. (2003) White cell telomere length and risk of premature myocardial infarction. Arterioscler Thromb Vasc Biol, 23, pp. 842-846.
5. Brown, ES, Varghese, FP and McEwen, BS. (2004) Association of depression with medical illness: Does cortisol play a role?. Biol Psychiatry, 55, pp. 1-9.
6. Cawthon, RM, Smith, KR, O'Brien, E., Sivatchenko, A. and Kerber, RA. (2003) Association between telomere length in blood and mortality in people aged 60 years or older. Lancet, 361, pp. 393-395.
7. Charney, DS. (1998) Monoamine dysfunction and the pathophysiology and treatment of depression. J Clin Psychiatry, 59, pp. 11-14.
8. Duman, RS and Monteggia, LM. (2006) A neurotrophic model for stress-related mood disorders. Biol Psychiatry, 59, pp. 1116-1127.
9. Duman, RS, Heninger, GR and Nestler, EJ. (1997) A molecular and cellular theory of depression. Arch Gen Psychiatry, 54, pp. 597-606.
10. Effros, RB. (2007) Telomerase induction in T cells: A cure for aging and disease?. Exp Gerontol, 42, pp. 416-420.
11. Epel, ES, Blackburn, EH and Lin, J. (2004) Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci USA, 101, pp. 17312-17315.
12. Epel, ES, Lin, J. and Wilhelm, FH (2006) Cell aging in relation to stress arousal and cardiovascular disease risk factors. Psychoneuroendocrinology, 31, pp. 277-287.
13. Forlenza, MJ and Miller, GE. (2006) Increased serum levels of 8-hydroxy-2′-deoxyguanosine in clinical depression. Psychosom Med, 68, pp. 1-7.
14. Franco, S., Blasco, MA and Siedlak, SL (2006) Telomeres and telomerase in Alzheimer's disease: Epiphenomena or a new focus for therapeutic strategy? Alzheimer's. Dementia, 2, pp. 164-168.
15. Groves, JO. (2007) Is it time to reassess the BDNF hypothesis of depression?. Mol Psychiatry, 12, pp. 1079-1088.
16. Haendeler, J., Hoffmann, J. and Diehl, JF (2004) Antioxidants inhibit nuclear export of telomerase reverse transcriptase and delay replicative senescence of endothelial cells. Circ Res, 94, pp. 768-775.
17. Hindmarch, I. (2002) Beyond the monoamine hypothesis: Mechanisms, molecules and methods. Eur Psychiatry, 17, pp. 294-299.
18. Honig, LS, Schupf, N., Lee, JH, Tang, MX and Mayeux, R. (2006) Shorter telomeres are associated with mortality in those with APOE epsilon4 and dementia. Ann Neurol, 60, pp. 181-187.
19. Ichiyoshi, H., Kiyozuka, Y., Kishimoto, Y., Fukuhara, S. and Tsubura, A. (2003) Massive telomere loss and telomerase RNA expression in dexamethasone-induced apoptosis in mouse thymocytes. Exp Mol Pathol, 75, pp. 178-186.
20. Irie, M., Asami, S., Nagata, S., Miyata, M. and Kasai, H. (2002) Psychological mediation of a type of oxidative DNA damage, 8-hydroxydeoxyguanosine, in peripheral blood leukocytes of non-smoking and non-drinking workers. Psychother Psychosom, 71, pp. 90-96.
21. Irie, M., Asami, S., Ikeda, M. and Kasai, H. (2003) Depressive state relates to female oxidative DNA damage via neutrophil activation. Biochem Biophys Res Commun, 311, pp. 1014-1018.
22. Karege, F., Perret, G., Bondolfi, G., Schwald, M., Bertschy, G. and Aubry, JM. (2002) Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res, 109, pp. 143-148.
23. Leonard, B. (2000) Stress, depression and the activation of the immune system. World J Biol Psychiatry, 1, pp. 17-25.
24. Martin-Ruiz, C., Dickinson, HO, Keys, B., Rowan, E., Kenny, RA and Von Zglinicki, T. (2006) Telomere length predicts poststroke mortality, dementia, and cognitive decline. Ann Neurol, 60, pp. 174-180.
25. Mattson, MP, Fu, W. and Zhang, P. (2001) Emerging roles for telomerase in regulating cell differentiation and survival: A neuroscientist's perspective. Mech Ageing Dev, 122, pp. 659-671.
26. McEwen, BS and Magarinos, AM. (2001) Stress and hippocampal plasticity: implications for the pathophysiology of affective disorders. Hum Psychopharmacol Clin Exp, 16, p. S7.
27. McEwen, BS, Davis, PG and Parsons, B. (1979) The brain as a target for steroid hormone action. Annu Rev Neurosci, 2, pp. 65-112.
28. McIntosh, LJ and Sapolsky, RM. (1996) Glucocorticoids may enhance oxygen radical-mediated neurotoxicity. Neurotoxicology, 17, pp. 873-882.
29. Musselman, DL, Evans, DL and Nemeroff, CB. (1998) The relationship of depression to cardiovascular disease: Epidemiology, biology, and treatment. Arch Gen Psychiatry, 55, pp. 580-592.
30. O'Brien, SM, Scott, LV and Dinan, TG. (2004) Cytokines: Abnormalities in major depression and implications for pharmacological treatment. Hum Psychopharmacol, 19, pp. 397-403.
31. Sapolsky, RM. (2000) Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry, 57, pp. 925-935.
32. Sapolsky, RM. (2000) The possibility of neurotoxicity in the hippocampus in major depression: A primer on neuron death. Biol Psychiatry, 48, pp. 755-765.
33. Sapolsky, RM, Krey, LC and McEwen, BS. (1985) Prolonged glucocorticoid exposure reduces hippocampal neuron number: Implications for aging. J Neurosci, 5, pp. 1222-1227.
34. Sheline, YI. (1996) Hippocampal atrophy in major depression: A result of depression-induced neurotoxicity?. Mol Psychiatry, 1, pp. 298-299.
35. Sheline, YI. (2000) 3D MRI studies of neuroanatomic changes in unipolar major depression: The role of stress and medical comorbidity. Biol Psychiatry, 48, pp. 791-800.
36. Simon, NM, Smoller, JW and McNamara, KL (2006) Telomere shortening and mood disorders: Preliminary support for a chronic stress model of accelerated aging. Biol Psychiatry, 60, pp. 432-435.
37. Sorrells, SF and Sapolsky, RM. (2007) An inflammatory review of glucocorticoid actions in the CNS. Brain Behav Immun, 21, pp. 259-272.
38. Tsuboi, H., Shimoi, K., Kinae, N., Oguni, I., Hori, R. and Kobayashi, F. (2004) Depressive symptoms are independently correlated with lipid peroxidation in a female population: Comparison with vitamins and carotenoids. J Psychosom Res, 56, pp. 53-58.
39. von Zglinicki, T. (2002) Oxidative stress shortens telomeres. Trends Biochem Sci, 27, pp. 339-344.
40. von Zglinicki, T., Serra, V. and Lorenz, M. (2000) Short telomeres in patients with vascular dementia: An indicator of low antioxidative capacity and a possible risk factor?. Lab Invest, 80, pp. 1739-1747.